Who can pay for innovative medicines?

Eur Respir J. 2013 Mar;41(3):495-6. doi: 10.1183/09031936.00135412.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biomedical Research
  • Drug Discovery / economics*
  • Drug Industry
  • Drug Therapy / economics
  • Economics, Pharmaceutical*
  • Europe
  • Financing, Government
  • Humans
  • Respiratory Tract Diseases / drug therapy*
  • Respiratory Tract Diseases / economics
  • United States